Articles

Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%

Effect of travoprost on intraocular pressure during 12 months of treatment for normal-tension glaucoma

Remodeling of the Connective Tissue Microarchitecture of the Lamina Cribrosa in Early Experimental Glaucoma

Cost-effectiveness of ranibizumab compared with photodynamic treatment of neovascular age-related macular degeneration

Human corneal epithelial cells, grown in the lab, are being used in preclinical trials, evaluating if it is possible to enhance the photorefractive keratectomy (PRK) procedure, according to a statement from the trial organizer, International Stem Cell Corporation (ISCO).

Triamcinolone acetonide prevents oxidative stress-induced tight junction disruption of retinal pigment epithelial cells

ESBA105, an anti-TNF alpha antibody fragment designed to reduce inflammation in patients undergoing cataract surgery, has begun a Phase Ib/IIa trial, according to an announcement from ESBATech AG, the antibody's developer.

Clinical evaluation of a rapid, pupil-based assessment of retinal damage associated with glaucoma

Ophthalmology Times Europe, in conjunction with Carl Zeiss Meditec, is to host a free online seminar aimed specifically at cataract and refractive surgeons, explaining how to integrate the Acri.LISA multifocal intraocular lens (IOL) into practice.

Virtual reality training improves wet-lab performance of capsulorhexis: results of a randomized, controlled study

It is not necessary for patients to remain face-down for more than 24 hours to ensure successful macular hole closure, according to study results published online ahead of print by the British Journal of Ophthalmology.

Prolacria (diquafosol tetrasodium ophthalmic solution) 2% has entered a Phase III trial for the treatment of dry eye disease, according to an announcement from the solution's developer, Inspire Pharmaceuticals, Inc.

Cataract Surgery Assisted by Anterior Endoscopy

Incisions made during sutureless vitrectomy may allow the entry of ocular surface fluid soon after surgery, according to study results published in the February 2009 issue of the American Journal of Ophthalmology.

Analysis of the possible benefits of aspheric intraocular lenses: Review of the literature

Combined Laser and Intravitreal Triamcinolone for Proliferative Diabetic Retinopathy and Macular Edema: One-year Results of a Randomized Clinical Trial

No clear link between cataract surgery and progressive age-related macular degeneration (AMD) could be established by a study published in the February issue of Ophthalmology.

A New Drug Application (NDA) for ganciclovir ophthalmic gel 0.15% against herpetic keratitis, submitted by Sirion Therapeutics, Inc, has been accepted for review by the FDA.

OPKO Health, Inc has received FDA marketing clearance on an imaging device and launched clinical trials of a new glaucoma shunt, the company has announced.

Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma

OptiMedica Corp has donated a PASCAL photocoagulator to non-profit organization ORBIS International, under a new partnership between the two companies.

Infrared features of classic choroidal neovascularisation in exudative age-related macular degeneration

Idiopathic elevated episcleral venous pressure and open-angle glaucoma

Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study

The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3RS) has awarded its annual prize to a project exploring the use of stem cells for treating glaucoma and other eye diseases.

A laser-based surgical device has been shown during trials to provide a safe, non-penetrating method of reducing intraocular pressure (IOP), according to study results published by the developer of the device, IOPtima Ltd.

Piggyback intraocular lens implant to correct severe refractive error after penetrating keratoplasty in pseudophakes

HIV-1-mediated delivery of a short hairpin RNA targeting vascular endothelial growth factor in human retinal pigment epithelium cells

Posterior lamellar keratoplasty? comparison of deep lamellar endothelial keratoplasty and Descemet stripping automated endothelial keratoplasty in the same patients: a patient's perspective

A single intravitreal injection of 4.0 mg vascular endothelial growth factor (VEGF) Trap-Eye is associated with bioactivity against diabetic macular oedema (DME), according to study results published in the January issue of the British Journal of Ophthalmology.